In other recent news, Enovix Corporation reported its financial results for the second quarter of 2025, surpassing revenue expectations with $7.5 million, compared to the forecasted $5.57 million. The company also reported a narrower-than-expected loss per share of $0.13, better than the anticipated $0.19. Following these earnings results, Canaccord Genuity raised its price target for Enovix to $22.00 from $20.00, maintaining a Buy rating. This adjustment came after Enovix's earnings call and a capital raise plan through a warrant dividend. Additionally, Enovix has established an 18,000-square-foot research and development center in Hyderabad, India, to accelerate the development of its second-generation battery platform. The facility employs around 40 full-time staff, primarily engineers and scientists. These developments highlight Enovix's ongoing efforts to advance its battery technology and strengthen its market position.